Skip to main content

Table 2 Univariate analysis of risk factors for treatment failure

From: Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

 

Univariate analysis

Factor

Hazard Ratio

p value

Chloroquine treatment

3.28 (1.41-7.63)

0.006

Female

0.93 (0.46-1.91)

0.85

Age (years)

0.96 (0.92-1.00)

0.03

Recruitment site

(Jalalabad as reference)

  

Taloqan

0.79 (0.26-2.43)

0.68

Maimana

3.06 (1.42-6.61)

0.004

Parasitaemia

0.86 (0.32-2.29)

0.76

Presence of gametocytes

1.13 (0.46-2.77)

0.784

Haemoglobin at admission (g/dl)

0.49 (0.37-0.65)

<0.001